Immuno-histochemical detection of human telomerase catalytic component, hTERT, in human colorectal tumor and non-tumor tissue sections.
Human telomerase is expressed in germ tissues and in the majority of primary tumors. Cell renewal tissues and some pre-cancerous tissues also have weak telomerase activity. Yet, neither the exact location and frequency of telomerase-positive cells nor the changes in telomerase expression during differentiation or carcinogenesis of individual cells are known. This paper reports on the expression of hTERT (telomerase reverse transcriptase) protein in tumor and non-tumor colorectal tissues by Western blotting and tissue sections by immunohistochemistry using antibodies raised against partial peptides of hTERT. Though telomerase activity and hTERT expression at both mRNA and protein levels were generally higher in tumor part than in non-tumor part, these two were not always correlated: expression of hTERT did not always give rise to high telomerase activity. Colonic carcinoma cell nuclei were stained with anti-hTERT antibodies but not with antigen-preabsorbed antibodies. In normal mucosa, hTERT protein was expressed, though weaker than in carcinoma, in all colonic crypt epithelial cells except those at the tip; the expressing-cell distribution was much wider than that of Ki-67 positive cells which were located at the bottom of the crypt. Isolated crypt contained a significant level of hTERT protein revealed by Western blotting, while having very weak telomerase activity. Telomerase activity was detected in epithelial cells only at the bottom half of the crypt. Specific hTERT-staining was positive in tissue lymphocytes but negative in almost all other stromal cells. It is of interest to see whether a significant level of hTERT expression with low telomerase activity is characteristic of physiologically regenerating tissues containing stem cells. In situ detection of the hTERT protein will permit further analysis of cancer diagnosis and stem cell differentiation.
Tahara
H
H
Department of Cellular and Molecular Biology, Hiroshima University School of Medicine, Hiroshima City, Japan.
Yasui
W
W
Tahara
E
E
Fujimoto
J
J
Ito
K
K
Tamai
K
K
Nakayama
J
J
Ishikawa
F
F
Tahara
E
E
Ide
T
T
D015153:Blotting, Western; D002277:Carcinoma / Q000201:enzymology* / Q000473:pathology; D020134:Catalytic Domain; D002467:Cell Nucleus / Q000201:enzymology; D003106:Colon / Q000201:enzymology*; D015179:Colorectal Neoplasms / Q000201:enzymology* / Q000473:pathology; D004268:DNA-Binding Proteins; D004847:Epithelial Cells / Q000201:enzymology; D006801:Humans; D007413:Intestinal Mucosa / Q000201:enzymology; D008214:Lymphocytes / Q000201:enzymology; D008969:Molecular Sequence Data; D009363:Neoplasm Proteins / Q000032:analysis*; D012313:RNA; D012333:RNA, Messenger / Q000032:analysis; D017154:Stromal Cells / Q000201:enzymology; D019098:Telomerase / Q000032:analysis* / Q000096:biosynthesis / Q000235:genetics
D004268:DNA-Binding Proteins; D009363:Neoplasm Proteins; D012333:RNA, Messenger; C422952:telomerase RNA; D012313:RNA; D019098:Telomerase